We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Pay-for-Delay Agreements Decline Drastically in 2012
EU Pay-for-Delay Agreements Decline Drastically in 2012
While the number of patent settlements between brand and generic drugmakers has risen in the EU for the fifth straight year, the number of agreements leading to pay-for-delay deals has dropped significantly.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor